A regulatory disclosure via a Form 4 filing with the U.S. Securities and Exchange Commission has confirmed that Alistair N. Sporck, Vice President of the Contactor Business Unit at AEHR Test Systems (NASDAQ:AEHR), has executed a sale of company common stock. The transaction was finalized on April 22, 2026.
The details of the divestment indicate that Sporck sold 2,000 shares of AEHR common stock. These shares were traded at a price point of $93.495 per share, bringing the total value of the transaction to roughly $186,990. It is noted that these specific shares were held indirectly under the auspices of a trust.
In the period following this sale, AEHR's stock has seen upward movement, reaching $97.30. This current trading level is approaching the company's 52-week high of $101.99. The stock's performance has been characterized by a significant year-to-date return of 382%.
Regarding Sporck’s remaining interest in AEHR, the executive holds 5,177 shares indirectly through the aforementioned trust. Furthermore, Sporck maintains a direct ownership stake of 20,294 shares, which encompasses shares that are currently subject to unvested restricted stock units.
Valuation assessments provide additional context for this transaction. According to data from InvestingPro, the stock is currently viewed as overvalued in relation to its Fair Value assessment, a factor that may be relevant to an insider's decision to reduce their total holdings.
AEHR Test Systems has also been engaged in significant capital and operational activities recently. The company completed a $60 million at-the-market stock offering, as documented in an SEC filing. This equity offering was conducted utilizing the company’s effective registration statement and serves to bolster its available financial resources.
On the operational front, AEHR announced a milestone production order valued at $41 million. This record-breaking order was placed by a hyperscale customer for AI processor ASICs. The contract includes high-power test and burn-in systems and represents the largest single order in the company's history. Deliveries related to this major contract are anticipated to commence during fiscal 2027.
Market analysts have also provided updated perspectives on the company. Freedom Broker has adjusted its price target for AEHR to $61 while maintaining a Hold rating. This assessment follows a third-quarter revenue report of $10.3 million, which fell slightly short of expected figures. Despite the revenue miss, the company reported record quarterly bookings of $37.2 million and an effective backlog that has exceeded $50 million.
In a similar vein, Lake Street raised its price target for the stock to $56 while retaining a Buy rating. This analyst's move was driven by the observation of strong momentum in bookings, despite the recent revenue shortfall. These combined factors highlight the current landscape of demand and financial positioning at AEHR Test Systems.